GT Biopharma, Inc.

    GT Biopharma, Inc.

    EEURONEXT:GTBP
    - -
    EUR
    - -
    - -
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    TTM
    Revenue per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Basic EPS, GAAP
    - -
    - -
    - -
    1,395,428.57
    -131,543.8
    -78,923.87
    -10,275.72
    -5,807.88
    -1,854.4
    -19.46
    -5.58
    - -
    - -
    - -
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    -275,714.29
    -4,958.03
    -3,262.18
    -972.88
    -1,490.56
    -498.85
    -14.18
    -6.5
    - -
    - -
    - -
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    -441,714.29
    -1,960,533.33
    -3,360,200
    -91,950.98
    2,562.87
    116.17
    -139.91
    -168.26
    20.5
    10.76
    5.41
    -0.75
    0.23
    0.22
    Tangible Book Value per Share
    -443,285.71
    -1,960,533.33
    -3,360,200
    -91,950.98
    -19.55
    -138.2
    -139.91
    -168.26
    20.5
    10.76
    5.41
    -0.75
    0.23
    0.22
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    1
    - -
    - -
    - -
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    -215.49
    -3,927.87
    -33,062.96
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Depreciation Expense
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Net Income, GAAP
    -1
    -23
    -21
    10
    -144
    -259
    -39
    -28
    -58
    -21
    -8
    -13
    -28
    -48
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    -136.14
    -38,506.56
    -79,374.07
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Working Capital
    -6
    -29
    -50
    -19
    -2
    -14
    -19
    -29
    22
    12
    7
    -2
    6
    8
    LT Debt
    - -
    1
    1
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Total Equity
    -6
    -30
    -51
    -19
    252
    11
    -19
    -29
    22
    12
    7
    -2
    6
    8
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    -68.97
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -1,036.73
    Return on Common Equity (%)
    - -
    - -
    - -
    - -
    - -
    -196.81
    - -
    - -
    - -
    -124.15
    -79.1
    - -
    - -
    -1,959.62

    Capital Structure

    USD

    •

    in mil. unless spec.
    Sep'25
    Dec'25
    Mar'26
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    6
    26
    35
    Market Capitalization
    - -
    - -
    - -

    Working Capital

    USD

    •

    in mil. unless spec.
    Sep'25
    Dec'25
    Mar'26
    Total Current Assets
    4
    8
    10
    Cash, Cash Equivalents & STI
    3
    7
    9
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    1
    2
    2
    Payables & Accruals
    1
    2
    2
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    -263.15%
    -165.21%
    -446.53%
    Free Cash Flow
    36.92%
    23.29%
    0.08%
    Net Income, GAAP
    -158.76%
    33.21%
    115.42%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    -1.64
    -2.17
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business